{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:55:08Z","timestamp":1791374108269,"version":"4.3.1"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Osteosarcoma (OS) remains difficult to cure once it becomes metastatic, recurrent, or resistant to chemotherapy, and immune checkpoint blockade has provided limited clinical benefit. The metabolic-immune tumor microenvironment (TME) is one barrier to effective immunity because malignant, stromal, and immune cells compete for nutrients and adapt to hypoxia, acidosis, and matrix-related constraints. This review examines how cancer-associated fibroblasts, extracellular matrix, myeloid and lymphoid populations interact with glucose\/lactate, glutamine, arginine, and lipid metabolism in OS. Public OS single-cell RNA sequencing datasets are used to illustrate cellular heterogeneity and are interpreted alongside published experimental evidence. OS-specific evidence is most developed for glycolysis and acidosis, glutamine dependence, myeloid regulation, and selected stromal and lipid-related pathways. Arginine-directed approaches, NK-cell immunometabolism, and most metabolism-ICB combinations remain preclinical or are supported mainly by mechanistic evidence from other tumor types. Together, these findings highlight the mechanisms with the strongest current support and the major gaps that remain before clinical translation.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1928701","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:25:11Z","timestamp":1791372311000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing osteosarcoma treatment: the impact of intratumoral metabolic reprogramming on immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Jiawei","family":"Yin","sequence":"first","affiliation":[{"name":"Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Trauma, Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Research Institute of Traumatology and Orthopaedics","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoqi","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Trauma, Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejun","family":"Zha","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Trauma, Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xieyuan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Trauma, Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Research Institute of Traumatology and Orthopaedics","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.02767","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"41","author":"Bielack","year":"2023","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1309\/UC6K-QHLD-9LV2-KENN","article-title":"Osteosarcoma: Anatomic and histologic variants","volume":"125","author":"Klein","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-450","article-title":"The genetic basis for inactivation of Wnt pathway in human osteosarcoma","volume":"14","author":"Du","year":"2014","journal-title":"BMC Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-43032-0_1","article-title":"Adjuvant and neoadjuvant chemotherapy for osteosarcoma: A historical perspective","volume":"1257","author":"Benjamin","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.27.0421","article-title":"Outcomes for children and adolescents with cancer: Challenges for the twenty-first century","volume":"28","author":"Smith","year":"2010","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27227","article-title":"Immunotherapy for osteosarcoma: Where do we go from here","volume":"65","author":"Wedekind","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215887","article-title":"Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential","volume":"547","author":"Wen","year":"2022","journal-title":"Cancer Lett"},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12885-019-6499-y","article-title":"Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells","volume":"20","author":"Yoshida","year":"2020","journal-title":"BMC Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-16-0088","article-title":"Immunotherapy with a HER2-targeting Listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a phase I trial in canine osteosarcoma","volume":"22","author":"Mason","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun Signal"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: Functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114504","article-title":"Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting","volume":"189","author":"Rimal","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3528","article-title":"Exploration of a new biomarker in osteosarcoma and association with clinical outcomes: (TOP2A+) cancer associated fibroblasts","volume":"25","author":"Xu","year":"2023","journal-title":"J Gene Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1136960","article-title":"Cancer-associated fibroblast infiltration in osteosarcoma: The discrepancy in subtypes pathways and immunosuppression","volume":"14","author":"Zhihao","year":"2023","journal-title":"Front Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05272-1","article-title":"LRRC15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity","volume":"611","author":"Krishnamurty","year":"2022","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: From mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041221","article-title":"Endogenous extracellular matrix regulates the response of osteosarcoma 3D spheroids to doxorubicin","volume":"15","author":"Cortini","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1158\/0008-5472.can-23-1307","article-title":"Osteosarcoma cells secrete CXCL14 that activates integrin \u03b111\u03b21 on fibroblasts to form a lung metastatic niche","volume":"84","author":"Xu","year":"2024","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309591","article-title":"Synergistic chemoimmunotherapy augmentation via sequential nanocomposite hydrogel-mediated reprogramming of cancer-associated fibroblasts in osteosarcoma","volume":"36","author":"Wang","year":"2024","journal-title":"Adv Mater"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-22-0593","article-title":"T cell-mediated development of stromal fibroblasts with an immune-enhancing chemokine profile","volume":"11","author":"Yan","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00549-7","article-title":"The advent of immune stimulating CAFs in cancer","volume":"23","author":"Tsoumakidou","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"Ozdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32387","article-title":"Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression","volume":"76","author":"Luo","year":"2022","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cas.12314","article-title":"Clinical significance of macrophage heterogeneity in human malignant tumors","volume":"105","author":"Komohara","year":"2014","journal-title":"Cancer Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-021-00598-w","article-title":"The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications","volume":"44","author":"Huang","year":"2021","journal-title":"Cell Oncol (Dordr)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00109-018-1711-0","article-title":"Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1","volume":"97","author":"Su","year":"2019","journal-title":"J Mol Med (Berl)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.10.011","article-title":"Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2\/STAT3 axis","author":"Han","year":"2019","journal-title":"Cancer Lett"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203388","article-title":"miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3\/JAK2\/STAT3 axis","volume":"13","author":"Liu","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-20-0591","article-title":"CSF1\/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment","volume":"20","author":"Fujiwara","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.1038\/s41467-022-34064-4","article-title":"Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.116110","article-title":"LIPA-driven reprogramming of tumor-associated macrophages shapes an immunosuppressive microenvironment in osteosarcoma","volume":"171","author":"Guo","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jbo.2017.10.002","article-title":"Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer","volume":"9","author":"Guan","year":"2017","journal-title":"J Bone Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105818","article-title":"SDF-1\/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy","volume":"75","author":"Jiang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-19-0154","article-title":"Infiltrating myeloid cells drive osteosarcoma progression via GRM4 regulation of IL23","volume":"9","author":"Kansara","year":"2019","journal-title":"Cancer Discov"},{"key":"B39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13045-024-01641-7","article-title":"Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells","volume":"17","author":"Pezzella","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113751","article-title":"Extracellular-vesicle-packaged S100A11 from osteosarcoma cells mediates lung premetastatic niche formation by recruiting gMDSCs","volume":"43","author":"Deng","year":"2024","journal-title":"Cell Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/0008-5472.can-06-3037","article-title":"The terminology issue for myeloid-derived suppressor cells","volume":"67","author":"Gabrilovich","year":"2007","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1158\/0008-5472.can-07-0211","article-title":"Re: The terminology issue for myeloid-derived suppressor cells","volume":"67","author":"Krystal","year":"2007","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: Markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/jci68189","article-title":"Myeloid-derived suppressor cell development is regulated by a STAT\/IRF-8 axis","volume":"123","author":"Waight","year":"2013","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601722","article-title":"The granulocyte progenitor stage is a key target of IRF8-mediated regulation of myeloid-derived suppressor cell production","volume":"198","author":"Netherby","year":"2017","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.03.004","article-title":"The unfolded protein response mediator PERK governs myeloid cell-driven immunosuppression in tumors through inhibition of STING signaling","volume":"52","author":"Mohamed","year":"2020","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10555-011-9281-4","article-title":"Angiogenesis and immunity: A bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy","volume":"30","author":"Tartour","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0902280106","article-title":"G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models","volume":"106","author":"Shojaei","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nm1609","article-title":"Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer","volume":"13","author":"Nagaraj","year":"2007","journal-title":"Nat Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042028","article-title":"Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers","volume":"201","author":"Bronte","year":"2005","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/jci45862","article-title":"Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice","volume":"121","author":"Lu","year":"2011","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101956","article-title":"Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells","volume":"208","author":"Molon","year":"2011","journal-title":"J Exp Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3109\/08820139.2012.680634","article-title":"Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives","volume":"41","author":"Raber","year":"2012","journal-title":"Immunol Invest"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-10-1439","article-title":"Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T cell function and promotes tumor progression","volume":"70","author":"Doedens","year":"2010","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-14-1491","article-title":"l-Arginine depletion blunts antitumor T cell responses by inducing myeloid-derived suppressor cells","volume":"75","author":"Fletcher","year":"2015","journal-title":"Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8 alpha+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.09.007","article-title":"Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity","volume":"26","author":"Broz","year":"2014","journal-title":"Cancer Cell"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J Exp Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4(+) T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.02.005","article-title":"Unleashing type-2 dendritic cells to drive protective antitumor CD4(+) T cell immunity","volume":"177","author":"Binnewies","year":"2019","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.10.020","article-title":"Type I interferon activates MHC class I-dressed CD11b(+) conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity","volume":"55","author":"Duong","year":"2022","journal-title":"Immunity"},{"key":"B70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1593\/neo.121572","article-title":"CD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network","volume":"15","author":"Boissonnas","year":"2013","journal-title":"Neoplasia"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.5.2763","article-title":"Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage","volume":"178","author":"Perrot","year":"2007","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193251","article-title":"CD103+ cDC1 dendritic cell vaccine therapy for osteosarcoma lung metastases","volume":"16","author":"Yang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22912","article-title":"Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8\/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1","volume":"8","author":"Palmerini","year":"2017","journal-title":"Oncotarget"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.21037\/atm-21-3928","article-title":"T cell exhaustion drives osteosarcoma pathogenesis","volume":"9","author":"Sun","year":"2021","journal-title":"Ann Transl Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2683","article-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","volume":"371","author":"Xu","year":"2021","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aab2610","article-title":"Glutamine-dependent alpha-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation","volume":"8","author":"Klysz","year":"2015","journal-title":"Sci Signal"},{"key":"B78","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","article-title":"Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation","volume":"40","author":"Nakaya","year":"2014","journal-title":"Immunity"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.7554\/elife.21330","article-title":"Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation","volume":"6","author":"Araujo","year":"2017","journal-title":"Elife"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/art.41019","article-title":"Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in MRL\/lpr mice and experimental autoimmune encephalomyelitis","volume":"71","author":"Kono","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.249","article-title":"Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment","volume":"17","author":"Kim-Schulze","year":"2009","journal-title":"Mol Ther"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24801","article-title":"Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis","volume":"61","author":"Guma","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008755","article-title":"CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma","volume":"13","author":"Cho","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500447","article-title":"NK cells preferentially target tumor cells with a cancer stem cell phenotype","volume":"195","author":"Ames","year":"2015","journal-title":"J Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-05-2429","article-title":"Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells","volume":"66","author":"Roda","year":"2006","journal-title":"Cancer Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer immunotherapy: from basic biology to clinical development","volume":"14","author":"Liu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.515051","article-title":"NDUFA4L2 regulated by HIF-1\u03b1 promotes metastasis and epithelial-mesenchymal transition of osteosarcoma cells through inhibiting ROS production","volume":"8","author":"Xu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225855","article-title":"The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma","volume":"13","author":"Avnet","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020311","article-title":"Exploring metabolic adaptations to the acidic microenvironment of osteosarcoma cells unveils sphingosine 1-phosphate as a valuable therapeutic target","volume":"13","author":"Cortini","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci Adv"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2017.04.002","article-title":"Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities","volume":"1868","author":"Ganapathy-Kanniappan","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2017.06.004","article-title":"Similarities and distinctions of cancer and immune metabolism in inflammation and tumors","volume":"26","author":"Andrejeva","year":"2017","journal-title":"Cell Metab"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1674-5","article-title":"VISTA is an acidic pH-selective ligand for PSGL-1","volume":"574","author":"Johnston","year":"2019","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1420370112","article-title":"Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T cell responses","volume":"112","author":"Liu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.709210","article-title":"Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13045-024-01598-7","article-title":"A single-cell and spatially resolved atlas of human osteosarcomas","volume":"17","author":"Zheng","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-8-88","article-title":"Altered metabolism in cancer","volume":"8","author":"Locasale","year":"2010","journal-title":"BMC Biol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13344","article-title":"Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15","volume":"56","author":"Yang","year":"2023","journal-title":"Cell Prolif"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04337-y","article-title":"N(6)-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability","volume":"149","author":"Liu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061371","article-title":"Progression-dependent altered metabolism in osteosarcoma resulting in different nutrient source dependencies","volume":"12","author":"Fritsche-Guenther","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202506214","article-title":"Lactate activates the HCAR1\/\u03b2-arrestin2\/PP2A signaling axis to mediate STAT1\/2 dephosphorylation and drive osteosarcoma progression","volume":"12","author":"Han","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01143","article-title":"Lactate in the regulation of tumor microenvironment and therapeutic approaches","volume":"9","author":"de la Cruz-Lopez","year":"2019","journal-title":"Front Oncol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00353","article-title":"Targeting tumor metabolism: A new challenge to improve immunotherapy","volume":"9","author":"Kouidhi","year":"2018","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6284","article-title":"Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1920413117","article-title":"Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity","volume":"117","author":"Hermans","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack","volume":"77","author":"Fang","year":"2023","journal-title":"Hepatology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.4331\/wjbc.v6.i4.281","article-title":"Targeting amino acid metabolism in cancer growth and anti-tumor immune response","volume":"6","author":"Ananieva","year":"2015","journal-title":"World J Biol Chem"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060770","article-title":"The pleiotropic effects of glutamine metabolism in cancer","volume":"11","author":"Bott","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.07.021","article-title":"Cytosolic aspartate availability determines cell survival when glutamine is limiting","volume":"28","author":"Alkan","year":"2018","journal-title":"Cell Metab"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11971","article-title":"Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer","volume":"7","author":"Hao","year":"2016","journal-title":"Nat Commun"},{"key":"B120","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1476-4598-7-14","article-title":"Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells","volume":"7","author":"Vie","year":"2008","journal-title":"Mol Cancer"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1186\/2049-3002-1-7","article-title":"Metabolic changes in cancer cells upon suppression of MYC","volume":"1","author":"Anso","year":"2013","journal-title":"Cancer Metab"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-020-0209-8","article-title":"Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma","volume":"8","author":"Ren","year":"2020","journal-title":"Cancer Metab"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201810_16068","article-title":"Significance of neoadjuvant chemotherapy (NACT) in limb salvage treatment of osteosarcoma and its effect on GLS1 expression","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1186\/s12967-024-05803-6","article-title":"SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K\/AKT\/mTOR signaling in osteosarcoma","volume":"22","author":"Huang","year":"2024","journal-title":"J Transl Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3796","article-title":"Alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming","volume":"18","author":"Liu","year":"2017","journal-title":"Nat Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.07.054","article-title":"Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis","volume":"20","author":"Palmieri","year":"2017","journal-title":"Cell Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1172\/jci131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J Clin Invest"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-18-0902","article-title":"Immunosuppressive immature myeloid cell generation is controlled by glutamine metabolism in human cancer","volume":"7","author":"Wu","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-19-0517","article-title":"Glutamine deprivation induces PD-L1 expression via activation of EGFR\/ERK\/c-Jun signaling in renal cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Mol Cancer Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","article-title":"Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity","volume":"80","author":"Byun","year":"2020","journal-title":"Mol Cell"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1700600114","article-title":"Metabolic origins of spatial organization in the tumor microenvironment","volume":"114","author":"Carmona-Fontaine","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B132","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/15384047.2016.1276136","article-title":"Combination therapy with L-arginine and \u03b1-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice","volume":"18","author":"He","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216412","article-title":"SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake","volume":"576","author":"Wang","year":"2023","journal-title":"Cancer Lett"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109210","article-title":"Arginine metabolism and deprivation in cancer therapy","volume":"118","author":"Zou","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01565","article-title":"Immunoregulatory interplay between arginine and tryptophan metabolism in health and disease","volume":"10","author":"Mondanelli","year":"2019","journal-title":"Front Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40425-019-0504-5","article-title":"Suppression of myeloid cell arginase activity leads to therapeutic response in a NSCLC mouse model by activating anti-tumor immunity","volume":"7","author":"Miret","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B137","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: The role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-11-4112","article-title":"ATP-citrate lyase: A key player in cancer metabolism","volume":"72","author":"Zaidi","year":"2012","journal-title":"Cancer Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.08.014","article-title":"PHD3 loss in cancer enables metabolic reliance on fatty acid oxidation via deactivation of ACC2","volume":"63","author":"German","year":"2016","journal-title":"Mol Cell"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.09.018","article-title":"Acetyl-CoA carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence","volume":"26","author":"Rios Garcia","year":"2017","journal-title":"Cell Metab"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2019.100670","article-title":"Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets","volume":"49","author":"Kopecka","year":"2020","journal-title":"Drug Resist Update"},{"key":"B144","article-title":"The role of cholesterol metabolism in cancer","volume":"9","author":"Ding","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.7150\/jca.83106","article-title":"CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation","volume":"14","author":"Tong","year":"2023","journal-title":"J Cancer"},{"key":"B146","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41419-023-05646-x","article-title":"NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m(5)C methylation","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1586","article-title":"Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index","volume":"14","author":"Wang","year":"2024","journal-title":"Clin Transl Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910698","article-title":"Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages","volume":"11","author":"Wu","year":"2019","journal-title":"EMBO Mol Med"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz6314","article-title":"Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy","volume":"13","author":"Liu","year":"2021","journal-title":"Sci Transl Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","article-title":"Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development","volume":"41","author":"O'Sullivan","year":"2014","journal-title":"Immunity"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-19-0702","article-title":"Fatty acid oxidation controls CD8+ tissue-resident memory T-cell survival in gastric adenocarcinoma","volume":"8","author":"Lin","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B154","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","article-title":"CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors","volume":"21","author":"Wang","year":"2020","journal-title":"Nat Immunol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0300891619868287","article-title":"PGC-1alpha activator-induced fatty acid oxidation in tumor-infiltrating CTLs enhances effects of PD-1 blockade therapy in lung cancer","volume":"106","author":"Wan","year":"2020","journal-title":"Tumori"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-18-0095","article-title":"PPAR-induced fatty acid oxidation in T cells increases the number of tumor-reactive CD8+ T cells and facilitates anti-PD-1 therapy","volume":"6","author":"Chowdhury","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab"},{"key":"B158","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1038\/s41598-019-40617-3","article-title":"A novel lactate dehydrogenase inhibitor, 1-(phenylseleno)-4-(trifluoromethyl) benzene, suppresses tumor growth through apoptotic cell death","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-19-0217","article-title":"Targeting glycolysis through inhibition of lactate dehydrogenase impairs tumor growth in preclinical models of Ewing sarcoma","volume":"79","author":"Yeung","year":"2019","journal-title":"Cancer Res"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032858","article-title":"Macrophage repolarization as a therapeutic strategy for osteosarcoma","volume":"24","author":"Anand","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1928701\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:25:13Z","timestamp":1791372313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1928701\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":160,"alternative-id":["10.3389\/fimmu.2026.1928701"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1928701","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1928701"}}